Curatio CME Institute

Prostate cancer is the most common newly diagnosed cancer in men. In the U.S., prostate cancer accounts for 25% of all new cancer diagnoses and 10% of all cancer deaths. This activity discusses the current and emerging therapies used to improve the management of bone disease in men with prostate cancer. Emerging clinical trial data is also discussed.

Estimated time to complete activity: 2 hours
Release date: July 2010
Expiration date: July 31, 2011

In this Ask the Expert CME series, Drs. Kenneth C. Anderson, Jean-Luc Harousseau, Sagar Lonial, Paul G. Richardson, and G. David Roodman respond to your clinical questions.

Release date: February 2010
Expiration date: February 28, 2011
Estimated time to complete activity: 0.25–1.0 hours

This CME-certified activity is based on information presented at a satellite symposium held on Friday, December 5, 2008, in Bethesda, Maryland, in conjunction with the 9th Annual Society of Urologic Oncology Winter Meeting.

Release Date: November 2009
Expiration Date: November 30, 2010 
Estimated time to complete activity: 1 hour

In this Expert Practice Article, Jan C. Buckner, MD, at the Mayo Clinic in Rochester, Minnesota reviews current data on targeted agents in development for the treatment of glioblastoma and provides insights on the practical considerations of using targeted agents to treat glioblastoma.

Release date: September 2009
Expiration date: September 30, 2010
Estimated time to complete activity: 0.50 hour